Drug Shortage Report for JARDIANCE
| Report ID | 118669 |
| Drug Identification Number | 02443945 |
| Brand name | JARDIANCE |
| Common or Proper name | Jardiance 30's |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | MARKETED |
| Active Ingredient(s) | EMPAGLIFLOZIN |
| Strength(s) | 25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | A10BK |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-06-30 |
| Actual start date | 2020-07-08 |
| Estimated end date | 2020-07-24 |
| Actual end date | 2020-07-21 |
| Shortage status | Resolved |
| Updated date | 2020-07-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2020-07-21 | French | Compare |
| v7 | 2020-07-21 | English | Compare |
| v6 | 2020-07-16 | French | Compare |
| v5 | 2020-07-16 | English | Compare |
| v4 | 2020-07-09 | French | Compare |
| v3 | 2020-07-09 | English | Compare |
| v2 | 2020-06-23 | French | Compare |
| v1 | 2020-06-23 | English | Compare |
Showing 1 to 8 of 8